Macroaxis: Personalized Investing
Simple Personalized Investing

SP 500   1,669   2.87  Index Moved Up 0.17%
ABT MDT SYK ISRG Long-Short Diversified Assets Alcohol Communication 
United States GSPC USD ...  |  Macroaxis Daily Picks


Processing
Collecting data for STJ

St Jude quote and profile

 
 Companies |  Insiders  | Dashboard  
     
46.78
  
STOCK
0.06  Macroaxis: 0.13 Up   0.13%  
Year To Date
30.2547.39
Last 1 Month(s)
40.6347.0
Trading Day 
46.747.39
May 21 2013 

Diversification Suggestion

Use St Jude to enhance returns of your portfolios. The stock experiences normal upward fluctuation
Analyze St Jude Medical Trend or Check current 30 days St Jude correlation with market (S&P 500)
1 Month Beta 0.62  
Highest Price:  
Lowest Price:  
47.0  
40.63  
May 17 2013 
April 22 2013 
As returns on market increase, St Jude returns are expected to increase less than the market. However during bear market, the loss on holding St Jude will be expected to be smaller as well.
St Jude Medical Inc Small BetaSt Jude Medical Beta Legend
STJ United States NYSE
St Jude Medical Inc
Healthcare
Medical Appliances and Equipment
Benchmark S&P 500
http://www.sjm.com
Contact Number: 651. 756. 2000
Currency: USD - US Dollar
Traded on New York Stock Exchange
    
Current Valuation14.14 B
Shares Outstanding287.4 M
Number of Shares Shorted8.77 M
Revenue5.45 B
 United States Nasdaq   0.97 % Macroaxis: 0.97 Moved Up  
 
 United States SP 500   0.17 % Macroaxis: 0.17 Moved Up  
 
 thisGreen STJ STJ agains markets  0.13 % Macroaxis: 0.13 Moved Up  
 
 United States NYSE   0.11 % Macroaxis: 0.11 Moved Up  
 
 United States Russel   0.08 % Macroaxis: 0.08 Moved Up  
 
Compare to Competition Get Alpha   Get Advice

St Jude Leadership

Daniel Starks Chairman, CEO and Pres
Jason Zellers Vice President General Counsel, Corporate Secretary
Jane Song President - Atrial Fibrillation
Thomas Northenscold Vice President - Information Technology, CIO

St Jude Price and Market Media

The median price of St Jude for the period between Sun, Apr 21, 2013 and Tue, May 21, 2013 is 41.68 with a coefficient of variation of 5.64. The daily time series for the period is distributed with a sample standard deviation of 2.42, arithmetic mean of 42.93, and mean deviation of 2.11. The Stock received substential amount of media coverage during this period.
St Jude         SP 500
Price Growth (%)
 
1
St. Jude Medical Given New 44.00 Price Target at Northland S...04/23/2013Macroaxis: News
2
St. Jude Medical Rating Reiterated by Oppenheimer04/26/2013Macroaxis: News
3
St. Jude Medical Inc. Health Management Associates Inc What ...04/29/2013Macroaxis: News
4
St. Jude Medical Gets CE Mark Approval For Allure Quadra CRT...05/01/2013Macroaxis: News
5
St. Jude Medical Enrolls First Patient in NextGeneration Qua...05/03/2013Macroaxis: News
6
St. Jude Medical Stock Rating Reaffirmed by TheStreet05/08/2013Macroaxis: News
7
St. Jude Medical Announces Results from Independent Analysis...05/10/2013Macroaxis: News
8
ST. JUDE MEDICAL INC. St. Jude Medical Announces First Patie...05/15/2013Macroaxis: News
9
St. Jude Medical Announces European Approval of 3D Vessel Re...05/17/2013Macroaxis: Wall Street Journal

St Jude Summary

St Jude Medical Inc [STJ] is traded on New York Stock Exchange in USA. It is located in Saint Paul, MN and employs 15,000 people. The company currently falls under 'Large-Cap' category with total capitalization of 11.75 B. St Jude Medical Inc runs under Healthcare sector within Medical Appliances and Equipment industry. This company has 287.4 M outstanding shares of which 8.77 M shares are at this time shorted by investors with about 3.7 days to cover shorted positions.
St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. more
Past Market
Over 30
Days
32
Out Of
100
 
Chance of
Less
Than
39 %
 
Follow St Jude with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add St Jude to your reader
 

St Jude Research Report

St Jude vs. Abbott

Correlation analysis and fundamentals comparison between St Jude Medical and Abbott Laboratories

St Jude Executives

Donald Zurbay CFO, Principal Accounting Officer and VP of Fin.

St Jude Directors

Michael Rocca Independent Director
Wendy Yarno Independent Director
Thomas Garrett Independent Director
Barbara Hill Independent Director
Stuart Essig Independent Director

St Jude Management

Eric MD President of Implantable Electronic Systems Division
J Weigelt Senior Manager - Investor and Corporate Relations
Michael Rousseau Acting Chief Marketing Officer and Group Pres

St Jude Fundamentals

Total Debt vs Number of Employees
Cash and Equivalents vs Total Asset
Total Debt vs EBITDA
Debt to Equity vs Total Asset

St Jude vs Competition

St Jude vs. Abbott Laboratories
St Jude vs. Medtronic Inc
St Jude vs. Stryker Corporation
St Jude vs. Intuitive Surgical Inc
St Jude vs. Zimmer Holdings Inc
St Jude vs. Boston Scientific Corporation
St Jude vs. Smith Nephew plc
St Jude vs. Edwards Lifesciences Corp
St Jude vs. Varian Medical Systems Inc

St Jude May 21 2013 Opportunity Range

Downside Deviation1.04
Information Ratio0.3197
Maximum Drawdown2.94
Value At Risk(1.10)
Potential Upside2.35

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium